These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35820038)

  • 21. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
    Masuka JT; Khoza S
    BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021.
    Chen F; Pan X; Liang H; Shen L; Wang Y; Chen Y; Lv H; Hu Y
    Hum Vaccin Immunother; 2022 Dec; 18(7):2152256. PubMed ID: 36484114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.
    Guo B; Page A; Wang H; Taylor R; McIntyre P
    Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of adverse events following immunization in China: Past, present, and future.
    Liu D; Wu W; Li K; Xu D; Ye J; Li L; Wang H
    Vaccine; 2015 Jul; 33(32):4041-6. PubMed ID: 25936727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
    Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
    Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A qualitative analysis of vaccine safety perceptions and concerns among caretakers in Uganda.
    Braka F; Asiimwe D; Soud F; Lewis RF; Makumbi I; Gust D
    Matern Child Health J; 2012 Jul; 16(5):1045-52. PubMed ID: 21660604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants.
    Cassidy C; MacDonald NE; Steenbeek A; Ortiz JR; Zuber PL; Top KA
    Hum Vaccin Immunother; 2016 Aug; 12(8):2010-2016. PubMed ID: 27159639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge, practice and approaches of health professionals to adverse events following immunization and their reporting in Albania.
    Mehmeti I; Nelaj E; Simaku A; Tomini E; Bino S
    Heliyon; 2017 Jun; 3(6):e00331. PubMed ID: 28664193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the adverse events following immunizations surveillance system in Harare City, Zimbabwe, 2016: a descriptive cross sectional study.
    Zvanaka S; Tsitsi J; Chonzi P; Shambira G; Gombe NT; Tshimanga M
    Pan Afr Med J; 2017; 28():308. PubMed ID: 29721138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.
    Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G
    Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study.
    Parrella A; Braunack-Mayer A; Gold M; Marshall H; Baghurst P
    BMC Health Serv Res; 2013 Aug; 13():313. PubMed ID: 23945045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
    Christou-Ergos M; Wiley KE; Leask J
    Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine safety surveillance informs public health policy beyond immunization: A case-series on bleeding following vaccination, Nepal, 2016-2018.
    Pradhan R; Sharma Gautam J; Tinkari BS; Adhikari N; Bose AS
    Vaccine; 2020 Sep; 38(40):6320-6326. PubMed ID: 32788134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine.
    Lv H; Pan X; Liang H; Wang Y; Hu Y
    Hum Vaccin Immunother; 2021 Nov; 17(11):4617-4622. PubMed ID: 34491888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Adverse Effects of COVID-19 Vaccines Experienced by Healthcare Workers at Guizhou Provincial Staff Hospital, China.
    Wei Y; Wang Y; Liu L; Zha Y; Yang Y; Wang Y; Roberts N; Li Y
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): a randomized controlled trial.
    Ateudjieu J; Stoll B; Nguefack-Tsague G; Tchangou C; Genton B
    Vaccine; 2014 Sep; 32(43):5662-8. PubMed ID: 25160064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics,2013.
    Chitkara AJ; Thacker N; Vashishtha VM; Bansal CP; Gupta SG
    Indian Pediatr; 2013 Aug; 50(8):739-41. PubMed ID: 24036641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Factors determining utilization of a Web site by parents in order to report side effects of vaccines].
    Kimpton A; Dubé E; Sauvageau C; De Serres G
    Can J Public Health; 2008; 99(6):456-9. PubMed ID: 19149385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the adverse events following immunization surveillance system, Ghana, 2019.
    Laryea EB; Frimpong JA; Noora CL; Tengey J; Bandoh D; Sabblah G; Ameme D; Kenu E; Amponsa-Achiano K
    PLoS One; 2022; 17(3):e0264697. PubMed ID: 35231049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.